What question did this study set out to answer?

The research aims to evaluate the safety and effectiveness of self-mixed 0.125% morphine gel for pain control in cancer lesions.

April 23, 2026Journal of Palliative Medicine0 citations

View Full Paper

The Use of Self-Mixed Morphine Gel 0.125% for Topical Pain Control in Painful Cancer Lesions

KNKelley Newcomer CRChahat Rana NLNicholas Lorusso

Key Points

The research aims to evaluate the safety and effectiveness of self-mixed 0.125% morphine gel for pain control in cancer lesions.
Conducted a small study evaluating morphine gel's efficacy and safety.
Focused on topical application for cancer-related pain.
Self-mixed 0.125% morphine gel demonstrated effectiveness in pain relief.
The gel was noted to be safe and affordable.

Abstract

This small study suggests that self-mixed 0.125% morphine gel is a safe, effective, and affordable option to control pain in cancer lesions. Larger studies are needed to confirm these results.

AI से पूछें

Bookmark

View Full Paper

AI से पूछें

Bookmark

View Full Paper

The Use of Self-Mixed Morphine Gel 0.125% for Topical Pain Control in Painful Cancer Lesions

Key Points

Abstract

Cite This Study

Also Consider

Also Consider